SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ArQule, Inc. (ARQL)
ARQL 20.000.0%Jan 16 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (531)4/11/2012 10:47:01 AM
From: Arthur Radley   of 545
 
Funny! Yesterday when they announced the deal they mentioned Citi and Leerink as the parties managing the deal. Now today when they have priced the shares they reveal that Lazard, RBC and Oppenheimer are in on the deal.

Black helicopter conspiracy----could these guys have been in on the massive sell off yesterday, knowing they had replacement shares @$7.30. Stock is now up over $7.80 after cratering to $7.00 yesterday.

On the good news---with breakout above $8.17 and now the $7.30 new shares--we should have a nice floor under the stock.........now just some good news from ASCO.

As with you--long time holder at nice entry levels compared to now---c-Met could be the next blockbuster.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext